Geode Capital Management, LLC Ab Cellera Biologics Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 113,773 shares of ABCL stock, worth $250,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares

113,773

Previous 113,653 0.11%

Holding current value

$250,300

Previous $294,000 13.27%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$2.48 - $3.15 $297 - $378	120 Added 0.11%	113,773 $333,000
Q3 2024 Nov 12, 2024	SELL	$2.39 - $3.49 $480,899 - $702,233	-201,213 Reduced 63.9%	113,653 $294,000
Q2 2024 Aug 09, 2024	BUY	$2.73 - $4.73 $156,975 - $271,975	57,500 Added 22.34%	314,866 $932,000
Q1 2024 May 13, 2024	BUY	$4.29 - $5.97 $5,242 - $7,295	1,222 Added 0.48%	257,366 $1.17 Million
Q4 2023 Feb 13, 2024	BUY	$3.91 - $5.93 $3,307 - $5,016	846 Added 0.33%	256,144 $1.46 Million
Q3 2023 Nov 13, 2023	BUY	$4.6 - $7.95 $16,670 - $28,810	3,624 Added 1.44%	255,298 $1.17 Million
Q2 2023 Aug 11, 2023	SELL	$5.66 - $7.59 $10.9 Million - $14.6 Million	-1,923,874 Reduced 88.43%	251,674 $1.63 Million
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $789,735 - $1.21 Million	108,035 Added 5.23%	2,175,548 $16.4 Million
Q4 2022 Feb 13, 2023	BUY	$9.48 - $14.52 $780,355 - $1.2 Million	82,316 Added 4.15%	2,067,513 $20.9 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $509,670 - $757,858	55,399 Added 2.87%	1,985,197 $19.6 Million
Q2 2022 Aug 12, 2022	BUY	$5.72 - $10.65 $9.88 Million - $18.4 Million	1,727,090 Added 852.01%	1,929,798 $20.6 Million
Q1 2022 May 13, 2022	BUY	$7.46 - $14.14 $6,266 - $11,877	840 Added 0.42%	202,708 $1.98 Million
Q4 2021 Feb 11, 2022	BUY	$12.99 - $17.73 $2.21 Million - $3.02 Million	170,204 Added 537.53%	201,868 $2.89 Million
Q3 2021 Nov 12, 2021	SELL	$14.85 - $21.34 $2.48 Million - $3.57 Million	-167,074 Reduced 84.07%	31,664 $634,000
Q2 2021 Aug 13, 2021	BUY	$20.19 - $34.17 $64,628 - $109,378	3,201 Added 1.64%	198,738 $4.37 Million
Q1 2021 May 12, 2021	BUY	$23.29 - $53.2 $126,487 - $288,929	5,431 Added 2.86%	195,537 $6.64 Million
Q4 2020 Feb 12, 2021	BUY	$39.0 - $58.9 $7.41 Million - $11.2 Million	190,106 New	190,106 $7.65 Million

Others Institutions Holding ABCL

# of Institutions

165

Shares Held

120M

Call Options Held

233K

Put Options Held

339K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $627M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Ab Cellera Biologics Inc. Transaction History